Korea Health Industry Development Institute (KHIDI) logo
Korea Drug Development Fund (KDDF) — New Drug R&D

KDDF New Drug R&D — staged-pipeline (seed)

Funds Korean pharmaceutical teams through staged support from lead compounds through clinical development.

OpenKorea Health Industry Development Institute (KHIDI)South Korea
Apply on funder portal
About

The Korea Drug Development Fund (KDDF) is a staged-pipeline grant mechanism co-funded by three Korean ministries — the Ministry of Health and Welfare (MOHW), the Ministry of Science and ICT (MSIT), and the Ministry of Trade, Industry and Energy (MOTIE) — with KHIDI serving as the lead executing institution for MOHW's share. The programme funds new drug R&D from early lead identification through Ph…

What this grant funds

Funds Korean new drug R&D from lead candidate identification through Phase 2 clinical trials via a staged, milestone-gated pipeline co-funded by MOHW, MSIT, and MOTIE.

Key facts
CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Multiple per year
Next deadlineiThe next date applications are due. Rolling means you can apply any time.—
Decision timeiTypical time from the deadline to the funder's decision.—
Project durationiHow long the funded work is expected to run.—
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.—
Funding analytics

Sign up free to see the funding breakdown

Create free accountSign in
Industries

Sign up free to see the industries in scope

Create free accountSign in
Eligibility criteria

Sign up free to see the full eligibility

Create free accountSign in
Application process

Sign up free to see how to apply

Create free accountSign in
Timeline

Sign up free to see the timeline

Create free accountSign in
Last verified: 24 Jul 2026Source: www.kddf.org